UPDATE: Deutsche Bank Initiates Coverage on Gen-Probe at Buy

According to Deutsche Bank, Gen-Probe GPRO coverage is initiated at Buy. Deutsche Bank said that GPRO is a leading player in the $4.5+ Bn MDx market, with a premier women's health and blood screening franchise. “Given our expectations for new product momentum to drive low double digit rev growth in the MT, we rate GPRO shares a Buy with a $70.50 PT.” Gen-Probe closed yesterday at $56.30.